Japan's Shionogi creating coronavirus vaccine using insects
Drugmaker aims for trials this year with eventual goal of 10 million doses
Japanese drugmaker Shionogi is working with the National Institute of Infectious Diseases to develop a coronavirus vaccine, with the help of insects. It hopes to begin clinical trials later this year. (Source photo by Reuters)
The technology behind the new medication was developed by Shionogi subsidiary UMN Pharma, a vaccine maker based in Akita, in northern Japan. The drugmaker is working with the health ministry in preparation for clinical trials. It hopes to eventually produce 10 million doses of the vaccine.